Evidence map›Paper›PMID 33657265›Full record

ArticleMolecular oncology2022

Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma.

Dongya Zhang, Yuxian Song, Dan Li, Xinghan Liu, Yuchen Pan, Liang Ding, Guoping Shi, Yong Wang, Yanhong Ni, Yayi Hou

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. [Latest Findings on Long Noncoding RNA in Tumor Microenvironment].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dongya ZhangThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.ORCID 0000-0002-3539-7429
Yuxian SongThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Dan LiThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Xinghan LiuThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Yuchen PanThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Liang DingThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Guoping ShiThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Yong WangState Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing, China.
Yanhong NiThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Yayi HouThe State Key Laboratory of Pharmaceutical Biotechnology and Central Laboratory of Stomatology Nanjing of Stomatological Hospital, Division of Immunology, Medical School, Nanjing University, China.
Nanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-associated fibroblasts (CAF) are the most abundant stromal cells in tumor and exert a pro-tumoral effect in cancer progression. Numerous evidence shows long non-coding RNA (lncRNA) abnormally regulates gene expression in various cancers. However, little is known about the role of lncRNA in the interaction between CAF and cancer cells. Here, we first identify an uncharacterized lncRNA, LOC100506114, which is significantly upregulated in CAF and is involved in the functional transformation of normal fibroblasts (NF) and CAF. Expression of LOC100506114 enhances the expression of fibroblast activation protein alpha and α-smooth muscle actin in NF and promotes malignant characteristics of NF and CAF in vivo and in vitro. The profile of gene co-expression analysis shows that growth differentiation factor 10 (GDF10) is positively correlated with the expression of LOC100506114. CAF promote stromal fibroblast activation and the proliferation and migration of tumor cells by secreting GDF10. Our data demonstrate that lncRNA plays a critical role in the interplay of stromal fibroblasts and tumor cells in oral squamous cell carcinoma.

Indexed as

Cancer-Associated FibroblastsCarcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsRNA, Long NoncodingCell Line, TumorCore Binding Factor Alpha 1 SubunitFibroblastsGrowth Differentiation Factor 10HumansSquamous Cell Carcinoma of Head and NeckCore Binding Factor Alpha 1 SubunitGDF10 protein, humanGrowth Differentiation Factor 10RNA, Long NoncodingRUNX2 protein, humancancer-associated fibroblastslncRNAtransformationtumor progression

Identifiers

PMID33657265
PMCPMC8807363
OpenAlexW3135882714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.